EQL Pharma AB (publ) announced approval of Mellozzan (melatonin). The pharmaceutical Mellozzan tablets 0.5mg, 1mg, 2mg, 3mg, 4mg and 5mg, has been approved for sale in Sweden by the Medical Products Agency. Mellozzan is a prescription drug used to treat insomnia in children 6 - 17 years of age with ADHD where other sleep support measures are not sufficient. It can also be taken by adults to treat the effects of jet lag for a short time. Mellozzan contains the hormone melatonin, a synthetic form of the body's own hormone that the brain produces to promote sleep. Medicines containing melatonin are available in Sweden in the form of prolonged-release tablets for the treatment of insomnia in the elderly and tablets for the treatment of jet lag in adults. But for the group of children with ADHD, so far there has only been pharmacy-manufactured licensed medicine, so-called ex-tempora, on the market. The product is expected to be launched during the current financial quarter.